European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Boehringer Ingelheim Middle East & Africa GmbH, Ingelheim a. Rhein, Germany

Watch
Boehringer Ingelheim Middle East & Africa GmbH

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Premium Service
Unlock Dossier
What is a Dossier?
A dossier provides comprehensive company details as a PDF, together with all underlying original publications and original data in one place.
The download feature is exclusively available for our paid plan. Upgrade your account to access:
Quick Dossier
Entire company details as a PDF
Power Dossier
Entire company details along with all original publications / original data bundled in a ZIP file
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more
Learn more
View plans

Name

Boehringer Ingelheim Middle East & Africa GmbH

Identification

Ut
District Court of Mainz HRB 45459
Lei
529900EZM0GN9OFSZO32
EUID
DET2304V.HRB45459

Address

Binger Str. 173, 55218 Ingelheim a. Rhein, Germany

Corporate purpose

The research, development, manufacture and marketing of human and veterinary prescription and non-prescription drugs, medical devices, food supplements and their respective precursors and the provision of related services.

Financial performance

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network

Legal Structure

Current legal representatives Legal form information · Proxy policies Premium
Premium
2Managing Director
14Authorized signatory (ppa)
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
CSV export

Investigative Journalism

Uncover International Corporate Connections
with our Free Investigative-Account

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
One known shareholder
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Cost of materials
Wages and salaries
Average salaries per employee
Pension provisions
Real estate
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans
Financial Statements Interactive sheets with CSV/Excel download Premium
Premium
Balance
from 2016 to 2024
Profit & Loss
from 2016 to 2024
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more View plans
Learn more View plans

Publications

11 May 2026
Managing Director: Mohammed Al-Tawil · Authorized signatory (ppa): Philipp A. Kohlhaas · No longer Managing Director: Marc M. E. Hasson · No longer Authorized signatory (ppa): Arif Haq
20 Feb 2026 via C.H. Boehringer Sohn AG & Co. KG also 02/05/2025, 02/10/2024, 08/04/2024, 21/12/2022, 08/01/2020, 13/12/2018, 03/01/2018, 12/01/2017, 25/02/2016
Shareholder: C.H. Boehringer Sohn AG & Co. KG
12 Jan 2026
Annual report for the year ending 31/12/2024 · Balance sheet for 31/12/2024 · Earnings statement for 31/12/2024
7 Jan 2026
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (4)
3 Jul 2025
Authorized signatory (ppa): Rene Weberskirch · No longer Authorized signatory (ppa): Mathieu Duchamp
17 Mar 2025
Annual report for the year ending 31/12/2023 · Balance sheet for 31/12/2023 · Earnings statement for 31/12/2023
5 Feb 2025 via Boehringer Ingelheim International GmbH also 16/02/2024, 13/03/2023, 12/01/2022, 13/01/2021, 13/02/2020, 23/01/2019, 01/02/2018, 09/01/2017, 02/12/2015
Shareholder: Boehringer Ingelheim International GmbH
12 Dec 2024
No longer Authorized signatory (ppa): Martin Mauer
24 Oct 2024
Authorized signatory (ppa): Jochen Gann
9 Oct 2024
Managing Director: Jose Soto Piñeiro · No longer Managing Director: Jens Schader · No longer Authorized signatory (ppa) (1)
26 Aug 2024
No longer Authorized signatory (ppa): Mohammed Al-Tawil · Authorized signatory (ppa) (6)
19 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholding: Boehringer Ingelheim Middle East & Africa GmbH
30 Jan 2024
Authorized signatory (ppa): Sandrine Bianchi
11 Jul 2023
Managing Director: Marc M. E. Hasson · Authorized signatory (ppa): Susanne Listl-Nörr, Evren Ozlu · No longer Managing Director: Torsten Pöhl · No longer Authorized signatory (ppa) (1)
13 Mar 2023
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
11 Jul 2022
Managing Director: Jens Schader · No longer Managing Director: Torsten Mau · No longer Authorized signatory (ppa) (1)
7 Mar 2022
Authorized signatory (ppa): Sven Sommerlatte
12 Jan 2022
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
5 Jan 2022
Authorized signatory (ppa): Alexander Roh
15 Apr 2021
Authorized signatory (ppa): Andrea Jakob · No longer Authorized signatory (ppa) (2)
20 Jan 2021
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
17 Nov 2020
Managing Director: Torsten Pöhl · Authorized signatory (ppa): Arif Haq · No longer Managing Director: Yew Looi Liew · No longer Authorized signatory (ppa) (3)
19 Jul 2019
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1)
25 Jan 2019
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
11 Oct 2017
Authorized signatory (ppa) (4) · No longer Authorized signatory (ppa) (3)
21 Jun 2017
Managing Director: Torsten Mau · No longer Managing Director: Ulrich Glas
13 Dec 2016
Authorized signatory (ppa) (3) · No longer Authorized signatory (ppa) (1) · Share­holder agreement · Corporate Purpose
1 Dec 2016
Original document: “Gesellschaftsvertrag / Satzung / Statut“
15 Oct 2015 via Dr.Karl Thomae GmbH
Shareholder: Dr.Karl Thomae GmbH
24 Jul 2014
Reg­is­tra­tion · Managing Director: Ulrich Glas, Yew Looi Liew · Authorized signatory (ppa) (10) · Address · Capital: €50,000 · Share­holder agreement · Proxy policy · Corporate Purpose
24 Jul 2014
Original document: “Liste der Gesellschafter“
9 Jul 2014
Original document: “Liste der Gesellschafter“
25 Jun 2014
Original document: “Gesellschaftsvertrag / Satzung / Statut“
There are no publications matching your search.

Mentions

26 Aug 2026 in Ler
Direct parent
26 Aug 2026 in Ler
Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.